The nootropic concept and its prospective implications

@article{Giurgea1982TheNC,
  title={The nootropic concept and its prospective implications},
  author={Corneliu E. Giurgea},
  journal={Drug Development Research},
  year={1982},
  volume={2}
}
  • C. Giurgea
  • Published 1982
  • Psychology
  • Drug Development Research
Giurgea, C.E.: The nootropic concept and its prospective implications. Drug. Dev. Res. 2:441–446, 1982. 
Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?
TLDR
It is demonstrated that the absence of any memory-improving action of nootropics in adrenalectomized animals cannot be ascribed to an effect of dosage. Expand
Klinische Bewertung der Wirksamkeit von Nootropika
Da tier- und humanexperimentell ermittelte pharmakologische und biochemische Untersuchungsergebnisse lediglich Aussagen zur Wirkung der Nootropika zulassen, mus die Bewertung der WirksamkeitExpand
Effects of Nefiracetam, a Novel Pyrrolidone‐type Nootropic Agent, on the Amygdala‐kindled Seizures in Rats
TLDR
The present study focused on the effects of NEF in amygdala‐kindled seizures and its potential for antiepileptic therapy. Expand
Pharmacological and Nonpharmacological Approaches to the Treatment of Dementia
TLDR
In this chapter, the medical treatment of dementia and the social and psychological interventions that may be directed against the disease are discussed. Expand
Anticonvulsant Properties of the Novel Nootropic Agent Nefiracetam in Seizure Models of Mice and Rats
TLDR
Nefiracetam is a novel pyrrolidone‐type nootropic agent, and it has been reported to possess various pharmacologic effects as well as cognition‐enhancing effects and its potential for antiepileptic therapy. Expand
Treatment of experimental destructive lesions of the duodenum by nootropics
TLDR
Clinicians have achieved more definite success than experimental workers with the use of nootropic drugs for the treatment of many diseases of the internal organs, including peptic ulcer. Expand
Pharmacotherapy of Memory Loss in the Geriatric Patient
  • V. Galizia
  • Medicine
  • Drug intelligence & clinical pharmacy
  • 1984
Memory loss is a common problem with advancing age and a prominent symptom in dementia. Categories of drugs used to reverse memory loss and enhance recall are reviewed. Positive results have beenExpand
The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by ß‐amyloid peptide
TLDR
The metabolic enhancer piracetam has been shown to improve mitochondrial dysfunction following brain aging and experimentally induced oxidative stress and is implicated in the pathogenesis of Alzheimer's disease. Expand
New Pharmacological Perspectives on Nootropic Drugs
TLDR
While complete agreement between pharmacologists has not yet been attained, the vast majority agree that nootropic drugs have at least the following properties in common: they improve some aspect of cognitive performance—usually learning and/or memory in animals. Expand
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia
TLDR
Present evidence suggests some therapeutic efficacy for nootropics and metabolically active compounds as well as alkylxanthines in the treatment of dementia. Expand
...
1
2
3
4
5
...

References

SHOWING 1-8 OF 8 REFERENCES
Effect of different psychoactive drugs on serum and brain tryptophan levels.
TLDR
The results obtained suggest that tryptophan may be involved to varying extents in the activity of different psychoactive compounds. Expand
Piracetam activity may differ according to the age of the recipient mouse.
TLDR
Piracetam significantly improves the learning capacity of young mice, but the drug is remarkably more active in improving the performance by old mice, suggesting that this compound is especially effective in restoring the neurobiological setting of the aging brain. Expand
The Pharmacology of Callosal Transmission: A General Survey
The study of interhemispheric relationships, the functions of the cerebral commissures and their role with respect to memory and learning is in active progress. The neuropharmacologist has a doubleExpand
Effect of the acquisition-enhancing drug piracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine.
TLDR
It is concluded that although Piracetam has no effect on the cerebral energy metabolism under normal conditions, it may have a beneficial effect under marginal conditions like those met during hypoxia, by virtue of its adenylate kinase stimulating action. Expand
GABA UPTAKE IN RAT BRAIN SLICES: INHIBITION BY GABA ANALOGUES AND BY VARIOUS DRUGS
TLDR
2‐Hydroxy‐GABA is the most potent inhibitor of GABA uptake yet described and these analogues are potential substrates for the GABA transport system and possible ‘false transmitters’. Expand